thiazolyl blue has been researched along with Peritoneal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinoshita, J; Kinuya, S; Ninomiya, I; Ohta, T; Oyama, K; Tsukada, T; Yagi, Y; Yashiro, M | 1 |
| Dickson, RB; Kanayama, N; Kobayashi, H; Lin, CY; Saga, Y; Suzuki, M; Terao, T | 1 |
2 other study(ies) available for thiazolyl blue and Peritoneal Neoplasms
| Article | Year |
|---|---|
Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Blotting, Western; Cell Line, Tumor; Coloring Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tissue Distribution; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |
Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase.
Topics: Animals; Binding, Competitive; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Membrane; Coloring Agents; Culture Media, Conditioned; DNA, Complementary; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; Fibrinolysin; Flow Cytometry; Genome; Humans; Membrane Glycoproteins; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Oligonucleotides, Antisense; Peritoneal Neoplasms; Protein Binding; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Serine Endopeptidases; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Transforming Growth Factor beta; Transforming Growth Factor beta1; Trypsin Inhibitor, Kunitz Soybean; Urokinase-Type Plasminogen Activator | 2004 |